Related references
Note: Only part of the references are listed.PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders
Solveig Tiepolt et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Evidence that a working memory cognitive phenotype within schizophrenia has a unique underlying biology
Brian Dean et al.
PSYCHIATRY RESEARCH (2022)
PET Imaging of brain muscarinic receptors with 18F-Fluorobenzyl-Dexetimide: A first in human study
Christopher C. Rowe et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2021)
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
Stephen K. Brannan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Loss of Basal Forebrain Cholinergic Neurons Following Adolescent Binge Ethanol Exposure: Recovery With the Cholinesterase Inhibitor Galantamine
Fulton T. Crews et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2021)
Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia
T. Scott Stroup et al.
JAMA PSYCHIATRY (2021)
Adolescent administration of Δ9-THC decreases the expression and function of muscarinic-1 receptors in prelimbic prefrontal cortical neurons of adult male mice
Miguel Garzon et al.
IBRO NEUROSCIENCE REPORTS (2021)
Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer's disease and cognition
Brian Dean et al.
NPJ SCHIZOPHRENIA (2021)
The influence of COMT rs4680 on functional connectivity in healthy adults: A systematic review
Kim A. Morris et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2020)
α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future
Alvin V. Terry et al.
NEUROPHARMACOLOGY (2020)
Muscarinic M1 and M4 receptors: Hypothesis driven drug development for schizophrenia
Brian Dean et al.
PSYCHIATRY RESEARCH (2020)
Higher levels of α7 nicotinic receptors, but not choline acetyltransferase, in the dorsolateral prefrontal cortex from a sub-group of patients with schizophrenia
Brian Dean et al.
SCHIZOPHRENIA RESEARCH (2020)
Widespread Changes in Positive Allosteric Modulation of the Muscarinic M1 Receptor in Some Participants With Schizophrenia
Shaun Hopper et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor
E. Scarr et al.
MOLECULAR PSYCHIATRY (2018)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
Relationship between muscarinic M-1 receptor binding and cognition in medication-free subjects with psychosis
Geor Bakker et al.
NEUROIMAGE-CLINICAL (2018)
Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia
Elizabeth Scarr et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2018)
Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease
Elizabeth Scarr et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats
Masanori Miyauchi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Changes in BQCA Allosteric Modulation of [3H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations
Brian Dean et al.
NEUROPSYCHOPHARMACOLOGY (2016)
COMT genotype is associated with differential expression of muscarinic M1 receptors in human cortex
Brian Dean et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2016)
The Cholinergic System: An Emerging Drug Target for Schizophrenia
Andrew Gibbons et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
α7 Nicotinic Receptor Agonist Enhances Cognition in Aged 3xTg-AD Mice with Robust Plaques and Tangles
Rodrigo Medeiros et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia
Andrew Stuart Gibbons et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA
E. Scarr et al.
TRANSLATIONAL PSYCHIATRY (2013)
Muscarinic Receptors: Their Roles in Disorders of the Central Nervous System and Potential as Therapeutic Targets
Elizabeth Scarr
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Differential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophrenia
Bin Tang et al.
PSYCHIATRY RESEARCH (2012)
Muscarinic M1 receptor sequence: Preliminary studies on its effects on cognition and expression
Elizabeth Scarr et al.
SCHIZOPHRENIA RESEARCH (2012)
Loss of Muscarinic M1 Receptor Exacerbates Alzheimer's Disease-Like Pathology and Cognitive Decline
Rodrigo Medeiros et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Pyramidal neurons
John M. Bekkers
CURRENT BIOLOGY (2011)
Effects of benzodiazepine treatment on cortical GABAA and muscarinic receptors: Studies in schizophrenia and rats
Mark C. McLeod et al.
PSYCHIATRY RESEARCH (2010)
Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia
E. Scarr et al.
MOLECULAR PSYCHIATRY (2009)
Altered M1 Muscarinic Acetylcholine Receptor (CHRM1)-Gαq/11 Coupling in a Schizophrenia Endophenotype
Hasib Salah-Uddin et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Accelerating new knowledge in schizophrenia
Carol A. Tamminga
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia
Anantha Shekhar et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?
Elizabeth Scarr et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Planning, decision-making and the COMT rs4818 polymorphism in healthy males
Panos Roussos et al.
NEUROPSYCHOLOGIA (2008)
Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophrenia
Brian Dean et al.
SCHIZOPHRENIA RESEARCH (2008)
Levels of [3H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1
Brian Dean et al.
SCHIZOPHRENIA RESEARCH (2008)
Human postmortem tissue: What quality markers matter?
Ana D. Stan et al.
BRAIN RESEARCH (2006)
Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia
Kelly A. Newell et al.
EXPERIMENTAL BRAIN RESEARCH (2006)
No change in cortical muscarinic M2, M3 receptors or [35S]GTPγS binding in schizophrenia
E Scarr et al.
LIFE SCIENCES (2006)
Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls
JE Strand et al.
EUROPEAN PSYCHIATRY (2005)
Investigation of M1/M4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder
Z Katerina et al.
NEUROPSYCHOPHARMACOLOGY (2004)
M1 receptor agonism, a possible treatment for cognitive deficits in schizophrenia
B Dean
NEUROPSYCHOPHARMACOLOGY (2004)
Muscarinic receptors in schizophrenia
B Dean et al.
CURRENT MOLECULAR MEDICINE (2003)
Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia
D Mancama et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia
TJ Raedler et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
α7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex
RB Levy et al.
JOURNAL OF NEUROSCIENCE (2002)
Decreased muscarinic(1) receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia
B Dean et al.
MOLECULAR PSYCHIATRY (2002)
A neurobiological basis for substance abuse comorbidity in schizophrenia
RA Chambers et al.
BIOLOGICAL PSYCHIATRY (2001)
Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia
A Marutle et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2001)
Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: A study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment
JM Crook et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Elucidating the role of muscarinic receptors in psychosis
CC Felder et al.
LIFE SCIENCES (2001)
Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
B Dean et al.
NEUROSCIENCE (2001)
Smoking and schizophrenia: abnormal nicotinic receptor expression
S Leonard et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
